The Global market for Next Generation Sequencing is poised to reach $10 billion by the end of 2020 growing at a CAGR of approximately 20%. The instruments and consumables is the largest segment with a share of around half of the market in 2013. The fastest growing segment is the services with a highest CAGR during the forecast period. The major players are interested in services segment as it provides additional revenue for the company at the same time, increases the sales of instruments and reagents. The major players operating in the NGS market are Illumina Inc (U.S.), Thermo Fisher Scientific (U.S.), Hoffmann-La Roche Ltd (Switzerland), Pacific Bioscieces (U.S.) Agilent Technologies (U.S.), BGI (Beijing Genomics Institute) (China), Qiagen (Netherlands), Biomatters Ltd (New Zealand), and Genomatix Software GmbH (Germany).
Currently, North America is the largest market for NGS. This is due to the increased awareness about the quick return of investments and accuracy. Asia Pacific is the fastest growing segment. The Next Generation Sequencing market can be segmented on the basis of Technology (Whole Genome Sequencing, Targeted Resequencing, Whole Exome Sequencing, RNA Sequencing, Chip Sequencing, De Novo Sequencing and Methyl Sequencing), Products (Instruments, Reagents & Consumables, and Services), End user (Hospitals & Healthcare Institutions, Academics, Biotech & Pharma Firms, and Others), Applications (Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture And Animal Research, Infectious Diseases, and Others) and Geography (North America, Europe, APAC & RoW).
Increasing applications in clinical diagnosis boosting the market growth, Speed, cost and accuracy to spur the market growth, Efficient replacement for traditional technologies (Microarrays), and Drug discovery applications demanding NGS technology are the major factors driving the growth of the market.
Legal & ethical issues to hamper the market growth, Interpretation of complex data, and Lack of skilled professionals are the major restraints that are hampering the NGS market growth.
What the report offers
Market Definition for the specified topic along with identification of key drivers and restraints for the market.
Market analysis for the Global Next Generation Sequencing Market, with region specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.ï¿½
Identification and analysis of the Macro and Micro factors that affect the Global Next Generation Sequencing market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
Key points in table of content
Review and forecast period years
General Study Assumptions
Econometric forecast models
MARKET OVERVIEW AND INDUSTRY TRENDS
Current market scenario
New developments in therapeutics
Porters Five Force Analysis
Bargaining Power of suppliers
Bargaining power of buyers
Degree of competition
Threat of substitution
Threat of new entrants
DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
Increasing applications in clinical diagnosis boosting the market growth
Speed, cost and accuracy to spur the market growth
Efficient replacement for traditional technologies (Microarrays)
Drug discovery applications demanding NGS technology
Legal & ethical issues to hamper the market growth
Interpretation of complex data
Lack of skilled professionals
In NGS Technology, Personalized Medicine & Biomarker
Interpretation Of Complex Data From NGS Platforms
Clinical Translation of Genomic Discoveries
GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION
Whole Genome Sequencing
Whole Exome Sequencing
De Novo Sequencing
Reagents & Consumables
By End Users
Hospitals & Healthcare Institutions
Biotech & Pharma Firms
Agriculture And Animal Research
GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENTATION BY GEOGRAPHY – REGIONAL SHARES AND FORECAST
Spain and Portugal
Australia and New Zealand
Rest of Asia Pacific
Middle East and Africa
Rest of Middle East and Africa
Rest of Latin America
Merger and Acquisition Analysis
Roche Holding Ag
Agilent Technologies, Inc
BGI (Beijing Genomics Institute)
Gatc Biotech Ag
Genomatix Software Gmbh
Thermo Fisher Scientific
Oxford Nanopore Technologies, Ltd
Perkin Elmer, Inc
ANALYST OUTLOOK FOR INVESTMENT OPPORTUNITIES
FUTURE OUTLOOK OF THE MARKET
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)